SNSS
Sunesis Pharmaceuticals, Inc.NASDAQ
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • timtrading | Send Message 29 Jul
    Reply
      • wilkinson99 | Send Message 29 Jul

        Premarket Top % Gainers: $TSRI 54%, $SNSS 48%, $URRE 28%, $EVOK 15%, $AMDA 12%, $XGTI 12%, $RGSE 11%, $SNMX 9%, $BCS 8% $GALE $PXLW $KONE
        Reply
          • Life Sciences Report | Send Message 29 Jun

            " $SNSS has a late-stage asset, potentially near European approval" - Maxim Jacobs. Read more: http://ow.ly/SipS301M4QF
            Reply
              • Life Sciences Report | Send Message 29 Jun

                "Our valuation increase for $SNSS reflects the encouraging results from the Qinprezo/Dacogen study"- Jacobs. More: http://ow.ly/nKCI301M5Ks
                Reply
                  • Alexander Valtsev | Send Message 13 Jun

                    Monday Morning's Market Insights: LinkedIn Corp ($LNKD), $EBIO, $MNKD, $SNSS: http://bit.ly/130616EBIO
                    Reply
                      • Life Sciences Report | Send Message 11 May

                        "We stay bullish on $SNSS; there's potentially a multibillion market opportunity for SNS-062"- Hartaj Singh. More: http://ow.ly/QKRe3007yMm
                        Reply
                          • Life Sciences Report | Send Message 27 Apr

                            "Significant potential remains in Europe for $SNSS's Qinprezo"- Maxim Jacobs. Read more: http://ow.ly/4naQcI
                            Reply
                              • Life Sciences Report | Send Message 20 Apr

                                "Near-term focus is on EU feedback on $SNSS's vosaroxin application"- Hartaj Singh. Read more: http://ow.ly/4mV6l8
                                Reply
                                  • Life Sciences Report | Send Message 6 Apr

                                    " $SNSS is going after registration for vosaroxin in the European Union"- George Zavoico. Read more: http://ow.ly/10nbQs
                                    Reply
                                      • Life Sciences Report | Send Message 16 Mar

                                        " $SNSS has enough cash runway until Q1/17"- Hartaj Singh. Read more: http://ow.ly/Zz4Lp
                                        Reply